PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+10.27%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.22B
AUM Growth
+$3.22B
(-9.3%)
Cap. Flow
-$300M
Cap. Flow
% of AUM
-9.3%
Top 10 Holdings %
Top 10 Hldgs %
41.38%
Holding
91
New
22
Increased
22
Reduced
19
Closed
23
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$107M |
| 2 |
Amazon
AMZN
|
$99.4M |
| 3 |
Charles Schwab
SCHW
|
$91.5M |
| 4 |
Alibaba
BABA
|
$85.5M |
| 5 |
Lam Research
LRCX
|
$63.9M |
Top Sells
| 1 |
Pfizer
PFE
|
$166M |
| 2 |
UnitedHealth
UNH
|
$152M |
| 3 |
HCA Healthcare
HCA
|
$133M |
| 4 |
Gilead Sciences
GILD
|
$107M |
| 5 |
Eli Lilly
LLY
|
$92.6M |
Sector Composition
| 1 | Healthcare | 49.09% |
| 2 | Technology | 9.49% |
| 3 | Industrials | 8.41% |
| 4 | Financials | 7.83% |
| 5 | Communication Services | 7.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Humana
HUM
$36.5B
| – | – | -186,935 | Closed | -$33.5M |
|
77
JD.com
JD
$44.1B
| – | – | -1,693,324 | Closed | -$44.1M |
|
78
Liberty Global Class C
LBTYK
$4.07B
| – | – | -680,964 | Closed | -$27.9M |
|
|
79
Eli Lilly
LLY
$657B
| – | – | -1,106,139 | Closed | -$92.6M |
|
80
Mastercard
MA
$538B
| – | – | -500,093 | Closed | -$45.1M |
|
81
Merck
MRK
$210B
| – | – | 0 | – | – |
|
82
MGIC Investment
MTG
$6.42B
| – | – | -4,104,737 | Closed | -$38M |
|
|
83
Pfizer
PFE
$141B
| – | – | -5,279,394 | Closed | -$166M |
|
84
PTC Therapeutics
PTCT
$3.92B
| – | – | 0 | – | – |
|
85
Rockwell Automation
ROK
$38.6B
| – | – | 0 | – | – |
|
86
Teladoc Health
TDOC
$1.37B
| – | – | -13,670 | Closed | -$305K |
|
|
RDUS
87
DELISTED
Radius Health, Inc.
RDUS
| – | – | -577,034 | Closed | -$40M |
|
|
AIMT
88
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| – | – | -996,112 | Closed | -$25.2M |
|
|
FOMX
89
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| – | – | -506,920 | Closed | -$3.72M |
|